The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters

被引:70
|
作者
Abdelnabi, Rana [1 ]
Foo, Caroline S. [1 ]
Zhang, Xin [1 ]
Lemmens, Viktor [1 ,2 ]
Maes, Piet [3 ,4 ]
Slechten, Bram [5 ]
Raymenants, Joren [6 ]
Andr, Emmanuel [5 ,6 ]
Weynand, Birgit [7 ]
Dallmeier, Kai [1 ,2 ,8 ]
Neyts, Johan [1 ,2 ,8 ,9 ]
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Chemotherapy, Dept Microbiol Immunol & Transplantat, B-3000 Leuven, Belgium
[2] Mol Vaccinol & Vaccine Discovery, Leuven, Belgium
[3] Katholieke Univ Leuven, Rega Inst, Dept Microbiol Immunol & Transplantat, Lab Clin & Epidemiol Virol, B-3000 Leuven, Belgium
[4] Zoonot Infect Dis Unit, Leuven, Belgium
[5] UZ Leuven Hosp, Dept Lab Med, B-3000 Leuven, Belgium
[6] Katholieke Univ Leuven, Rega Inst, Dept Microbiol Immunol & Transplantat, Lab Clin Bacteriol & Mycol, B-3000 Leuven, Belgium
[7] Katholieke Univ Leuven, Div Translat Cell & Tissue Res, Translat Cell & Tissue Res, Dept Imaging & Pathol, B-3000 Leuven, Belgium
[8] GVN, Global Virus Network, Leuven, Belgium
[9] Katholieke Univ Leuven, Rega Inst Med Research, Herestraat 49 box 1030, B-3000 Leuven, Belgium
关键词
COVID-19; SARS-CoV-2; VoC; Omicron; Hamsters; Infectivity; EFFICIENT REPLICATION;
D O I
10.1016/j.antiviral.2022.105253
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The emergence of SARS-CoV-2 variants of concern (VoCs) has exacerbated the COVID-19 pandemic. End of November 2021, a new SARS-CoV-2 variant namely the omicron (B.1.1.529) emerged. Since this omicron variant is heavily mutated in the spike protein, WHO classified this variant as the 5th variant of concern (VoC). We previously demonstrated that the ancestral strain and the other SARS-CoV-2 VoCs replicate efficiently in and cause a COVID19-like pathology in Syrian hamsters. We here wanted to explore the infectivity of the omicron variant in comparison to the ancestral D614G strain in the hamster model. Strikingly, in hamsters that had been infected with the omicron variant, a 3 log10 lower viral RNA load was detected in the lungs as compared to animals infected with D614G and no infectious virus was detectable in this organ. Moreover, histopathological examination of the lungs from omicron-infected hamsters revealed no signs of peri-bronchial inflammation or bronchopneumonia.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant
    Farias, Jessica P.
    Pinheiro, Josilene R.
    Andreata-Santos, Robert
    Fogaca, Mayanna M. C.
    Brito, Ruth da Silva D.
    da Cruz, Edgar F.
    de Castro-Amarante, Maria F.
    Pereira, Samuel S.
    Almeida, Shirley dos Santos
    Moreira, Ludimila M.
    Simoes, Rafael da Conceicao
    Luiz, Wilson B.
    Birbrair, Alexander
    Belmok, Aline
    Ribeiro, Bergmann M.
    Maricato, Juliana T.
    Braconi, Carla T.
    Ferreira, Luis C. de Souza
    Janini, Luiz M. R.
    Amorim, Jaime Henrique
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
  • [32] COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a at the end of the tunnel?
    Mattiuzzi, Camilla
    Henry, Brandon M.
    Lippi, Giuseppe
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 118 : 167 - 168
  • [33] Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions
    Islam, Fahadul
    Dhawan, Manish
    Nafady, Mohamed H.
    Emran, Talha Bin
    Mitra, Saikat
    Choudhary, Om Prakash
    Akter, Aklima
    [J]. ANNALS OF MEDICINE AND SURGERY, 2022, 78
  • [34] Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
    Dejnirattisai, Wanwisa
    Shaw, Robert H.
    Supasa, Piyada
    Liu, Chang
    Stuart, Arabella S. V.
    Pollard, Andrew J.
    Liu, Xinxue
    Lambe, Teresa
    Crook, Derrick
    Stuart, Dave I.
    Mongkolsapaya, Juthathip
    Nguyen-Van-Tam, Jonathan S.
    Snape, Matthew D.
    Screaton, Gavin R.
    [J]. LANCET, 2022, 399 (10321): : 234 - 236
  • [35] Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study
    Sheward, Daniel J.
    Kim, Changil
    Ehling, Roy A.
    Pankow, Alec
    Dopico, Xaquin Castro
    Dyrdak, Robert
    Martin, Darren P.
    Reddy, Sai T.
    Dillner, Joakim
    Hedestam, Gunilla B. Karlsson
    Albert, Jan
    Murrell, Ben
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (06): : 813 - 820
  • [36] Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant
    Ren, Wenlin
    Zhang, Yu
    Rao, Juhong
    Wang, Ziyi
    Lan, Jun
    Liu, Kunpeng
    Zhang, Xuekai
    Hu, Xue
    Yang, Chen
    Zhong, Guocai
    Zhang, Rong
    Wang, Xinquan
    Shan, Chao
    Ding, Qiang
    [J]. MBIO, 2023, 14 (02):
  • [37] Detecting SARS-CoV-2 Omicron B.1.1.529 Variant in Wastewater Samples by Using Nanopore Sequencing
    Rasmussen, Lasse D.
    Richter, Stine R.
    Midgley, Sofie E.
    Franck, Kristina T.
    [J]. EMERGING INFECTIOUS DISEASES, 2022, 28 (06) : 1296 - 1298
  • [38] A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)
    Lu, Yuying
    Li, Qianlin
    Fan, Huahao
    Liao, Conghui
    Zhang, Jingsong
    Hu, Huan
    Yi, Huaimin
    Peng, Yuanli
    Lu, Jiahai
    Chen, Zeliang
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 353 - 367
  • [39] Characteristics of the SARS-CoV-2 Omicron (B.1.1.529) Variant and Emerging Impact on Global Public Health
    Islam, Md Rabiul
    Nasreen, Waheeda
    Anjum, Ramisa
    Shahriar, Mohammad
    Roy, Arpita
    Dhama, Kuldeep
    Bhuiyan, Mohiuddin Ahmed
    [J]. CLINICAL PATHOLOGY, 2022, 15
  • [40] Fractional order mathematical model for B.1.1.529 SARS-Cov-2 Omicron variant with quarantine and vaccination
    S. Dickson
    S. Padmasekaran
    Pushpendra Kumar
    [J]. International Journal of Dynamics and Control, 2023, 11 : 2215 - 2231